Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 9, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 5
| |||||||
Akari Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 3K |
—
|
—
| +68.18% | 7.4K |
Feb 9
| |||||||
Swk Holdings Corp
| 1.9K |
$17.64 | $33,498.36 | +44.34% | 6.18K |
Dec 30
| |||||||
Renovacor, Inc.
| -18.80K |
—
|
—
| -100.00% |
0
|
Dec 1
| |||||||
Swk Holdings Corp
| 1.97K |
$17.00 | $33,507.00 | +85.25% | 4.28K |
Sep 30
| |||||||
Swk Holdings Corp
| 1.14K |
$17.47 | $19,863.39 | +96.77% | 2.31K |
Jun 30
| |||||||
Renovacor, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Renovacor, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Swk Holdings Corp
| 1.18K |
$16.88 | $19,834.00 |
∞
| 1.18K |
Mar 31
| |||||||
Swk Holdings Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eyepoint Pharmaceuticals, Inc.
| 2.5K |
—
|
—
| +131.58% | 4.4K |
Feb 9
| |||||||
Renovacor, Inc.
| 18.8K |
—
|
—
| +434.28% | 23.13K |
Jan 24
| |||||||
Renovacor, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 3
| |||||||
Renovacor, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 1.9K |
—
|
—
|
∞
| 1.9K |
Feb 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 15
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ii-Vi Inc
|
0
|
$24.31 | -$44,432.50 |
—
| 30.55K |
Apr 28
|
Scheduled
| ||||||
Ii-Vi Inc
|
0
|
$26.16 | -$61,035.00 |
—
| 30.55K |
Jan 31
| |||||||
Ii-Vi Inc
| -4.40K |
$29.36 | -$129,169.92 | -12.59% | 30.55K |
Dec 23
|
Scheduled
| ||||||
Ii-Vi Inc
|
0
|
$19.14 | -$25,279.60 |
—
| 34.95K |
Sep 8
| |||||||
Ii-Vi Inc
| 3.7K |
$21.67 | $80,092.32 | +11.83% | 34.95K |
Aug 20
| |||||||
Ii-Vi Inc
|
0
|
$18.57 | -$10,354.00 |
—
| 31.25K |
Mar 30
| |||||||
Ii-Vi Inc
| 4.49K |
$17.84 | $80,012.40 | +16.76% | 31.25K |
Aug 15
| |||||||
Cannapharmarx, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 27
| |||||||
Cannapharmarx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ii-Vi Inc
| 5.72K |
—
|
—
| +27.18% | 26.77K |
Aug 16
| |||||||
Ii-Vi Inc
| 4.13K |
—
|
—
| +24.45% | 21.05K |
Aug 17
| |||||||
Ii-Vi Inc
| 4.31K |
—
|
—
| +34.21% | 16.91K |
Aug 18
| |||||||
Ii-Vi Inc
| 4.65K |
—
|
—
| +58.49% | 12.6K |
Aug 20
| |||||||
Ii-Vi Inc
| 325 |
$28.20 | $9,165.00 | +8.90% | 3.98K |
Jan 25
| |||||||
Ii-Vi Inc
| 1.98K |
—
|
—
| +117.91% | 3.65K |
Aug 21
| |||||||
Ii-Vi Inc
| 1K |
$23.60 | $23,600.00 | +148.15% | 1.68K |
Aug 17
| |||||||
Ii-Vi Inc
|
0
|
—
|
—
|
—
|
0
|
Aug 15
| |||||||
Ii-Vi Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 7
| |||||||
Ii-Vi Inc
| 475 |
$17.64 | $8,379.95 | +237.50% | 675 |
Dec 9
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.